As part of the formal validation following CLIA guidelines, DKK1 staining was shown to be localized to tumor cells in G/GEJ resections with a wide dynamic signal range, therefore demonstrating specificity and sensitivity. The gene discussed is DKK1; the disease is neoplasm.